15 Leading Clinics for Uterine Fibroid Care Across the U.S.: An Analytical Guide to Specialized Treatment Programs
Uterine fibroids, clinically termed leiomyomas, are benign tumors of the uterine muscle and rank among the most frequently diagnosed gynecologic conditions in women of reproductive age. 1 Research consistently shows that an estimated 70% to 80% of women develop fibroids by age 50, with Black women disproportionately affected, often developing them earlier and experiencing more severe symptoms. 2 Against this backdrop, the U.S. uterine fibroids treatment devices market was estimated at USD 2.77 billion in 2024 and is projected to grow at a compound annual growth rate of 9.3% from 2025 to 2030. 3 The broader global treatment market is expected to reach USD 8.17 billion by 2031 at an 8.68% CAGR. 4
Understanding the Fibroid Treatment Landscape
Treatment for uterine fibroids is no longer limited to hysterectomy or open myomectomy. The American College of Obstetricians and Gynecologists (ACOG) provides clinical guidance covering a range of modalities, from hormone-based medications to minimally invasive surgical and procedural options. 5 Interventional radiology specifically offers uterine artery embolization (UAE), also called uterine fibroid embolization (UFE), as a minimally invasive alternative recognized by the Society of Interventional Radiology. 6 MRI-guided focused ultrasound represents an additional non-invasive pathway, described by the U.S. Food and Drug Administration as an approved modality for treating uterine fibroids. 7
Despite the availability of these alternatives, research indicates that 96% of women with fibroids still undergo surgical intervention, underscoring an ongoing awareness gap in the patient community. 8 Women with fibroid symptoms also report measurable economic consequences, with one peer-reviewed study published in the Journal of Occupational and Environmental Medicine finding that affected employees report 33% lost productivity, translating to an estimated cost burden of $387 per week. 9 These figures reinforce why access to specialized, multidisciplinary fibroid care centers has become a priority in women's health policy discussions.
Major Academic Medical Centers With Dedicated Fibroid Programs
Several of the nation's highest-ranked academic institutions operate structured fibroid care programs that integrate gynecology, interventional radiology, and reproductive endocrinology. Mayo Clinic in Rochester, Minnesota, is consistently cited for its multidisciplinary approach, offering options that range from MRI-guided focused ultrasound to laparoscopic and robotic-assisted surgery within a single coordinated care pathway. 10 Cleveland Clinic in Ohio operates a dedicated Fibroid Clinic that pairs sub-specialists in gynecology with interventional radiologists, allowing patients to receive both procedural and surgical evaluations during the same clinical episode. 11
Johns Hopkins Medicine in Baltimore hosts a Center for Uterine Fibroid Treatment with an explicit emphasis on uterine-sparing procedures, positioning minimally invasive techniques as the primary pathway before hysterectomy is considered. 12 Brigham and Women's Hospital in Boston leverages its designation within the National Centers of Excellence in Women's Health to deliver individualized fibroid management programs covering medical, surgical, and interventional options. Penn Medicine's Penn Center for Integrated Fibroid Care similarly provides access to gynecology, gynecological surgery, radiology, and fertility specialists within one integrated system, and explicitly acknowledges that Black women are three times more likely to have fibroids than white women. 13
Specialized Interventional Radiology Clinics Across Regions
Beyond academic centers, a distinct category of standalone and regional interventional radiology clinics has expanded access to UFE across the country. Georgia Endovascular, serving the greater Atlanta area, reports having performed over 40,000 procedures with a stated symptom relief rate exceeding 90%, using board-certified and fellowship-trained interventional radiologists. 14 The Atlanta Fibroid Center, founded in 2005 by Dr. John Lipman, marked its 20th anniversary in October 2025 having helped more than 10,000 women avoid hysterectomy through UFE, and raised $15,000 for a local food-insecurity charity at its anniversary event. 15
Texas Endovascular, serving Houston and Dallas-Fort Worth, mirrors this same 40,000-plus procedure volume and greater-than-90% symptom relief benchmark. 16 California Vascular Associates in Los Angeles offers UFE performed through a tiny skin nick using advanced catheter and imaging technology, emphasizing no general anesthesia and outpatient recovery within a few days rather than the weeks associated with open surgery. 17 The Maryland Fibroid Clinic, led by board-certified interventional radiologist Dr. Scott Buckner in the greater Baltimore area, focuses exclusively on UFE as a surgery-free solution and conducts initial consultations directly with the treating physician. 18

Multi-Location Networks and Regional Centers
USA Fibroid Centers operates one of the largest multi-state networks for non-surgical fibroid treatment, with locations that include Indianapolis, Indiana; Paramus and Passaic, New Jersey; and Kent, Washington, among many others. The network holds a 4.9-star patient rating from over 3,500 reviews and is accredited by the Accreditation Association for Ambulatory Health Care (AAAHC). 19 Viva Eve in New York City markets a proprietary Fibroid 360 treatment model combining surgical and nonsurgical options, including UFE, through an integrated multidisciplinary team operating across Manhattan and Forest Hills locations. 20
The Fibroid Institute, with a Charleston, South Carolina location led by Dr. Suzanne Slonim, a board-certified interventional radiologist trained at George Washington University School of Medicine, UCLA, and Stanford University, reports that over 90% of patients experience major symptom reduction or elimination through UFE, with a 7-to-10-day recovery window. 21 Premier Endovascular in West Orange, New Jersey, frames UFE as a nonsurgical procedure that treats fibroids at their source while preserving the uterus, noting coverage by most major insurance plans. 22 SACMD.com, led by board-certified interventional radiologist Dr. Albert Chun and serving the Washington, D.C. metropolitan area from locations in Camp Springs, Waldorf, Silver Spring, and Reston, positions itself as a high-volume provider leveraging advanced embolic microsphere technology. 23
Additional Notable Programs: Midwest, West Coast, and Mid-Atlantic
Mount Sinai Health System in New York integrates specialized diagnostic imaging with advanced robotic-assisted myomectomy at its Fibroid Center. UCLA Health in Los Angeles operates a centralized fibroid treatment program emphasizing fertility preservation through minimally invasive surgery. Northwestern Medicine in Chicago offers research-backed options including radiofrequency ablation (RFA), which is also being evaluated in the ULTRA Registry, a nationwide observational study coordinated by UCSF that tracks long-term safety and efficacy of laparoscopic RFA versus myomectomy over a 36-month follow-up. 24 MedStar Health in Washington, D.C. maintains a high-volume fibroid program specializing in UFE and laparoscopic treatments.
Prospero Vascular and Interventional, a same-day outpatient clinic in Hayward serving the East San Francisco Bay Area, was founded by Dr. David Soto, a board-certified and fellowship-trained vascular and interventional radiologist with over 15 years of experience. The practice offers uterine artery embolization in a comfortable outpatient environment as an alternative to large incisions or prolonged hospital stays. 25 The Fibroid Center at Image Guided Surgery, serving patients near Stafford, Virginia, is led by Dr. Gaugau, described as a nationally recognized interventional surgeon, and uses real-time image guidance to deliver embolic agents directly to fibroids through a small catheter inserted via a tiny incision. 26 Rutgers New Jersey Medical School and University Hospital round out the list, where associate professor Pratik A. Shukla actively advances clinical UFE care while simultaneously researching disparities in fibroid diagnosis and treatment access among underserved communities. 27
Key Factors and Risks Patients Should Evaluate
Selecting a fibroid care program requires weighing several clinical and logistical factors. Not all treatment modalities are appropriate for every patient. UFE, for example, is generally not recommended for women who plan to become pregnant in the near term, as evidence on post-procedure fertility outcomes remains an area of ongoing study. Eligibility for specific procedures depends on fibroid size, number, location within the uterus, symptom severity, and individual health history. Hormone therapies such as oral GnRH antagonists may shrink fibroids temporarily but do not eliminate them permanently, and expanded payer coverage for these medications is a relatively recent development. 4
Patients should also consider accreditation status, as AAAHC-accredited ambulatory surgery centers meet documented standards for safety and quality. Insurance coverage for UFE is accepted by most major plans at many listed centers, but preauthorization processes vary, and out-of-pocket exposure can differ significantly. Supply-chain risks for embolic agents and MRI contrast media represent operational vulnerabilities acknowledged within the industry that could affect scheduling and availability at some facilities. 4 Consulting with both a gynecologist and an interventional radiologist before deciding on any single treatment path allows patients to receive a complete clinical picture across the full range of options.
Sources
- National Cancer Institute (NCI), U.S. National Institutes of Health - cancer.gov/about-cancer/causes-prevention/risk/tumor/fibroids-fact-sheet
- Rutgers University / Rutgers Health - rutgers.edu/news/breaking-boundaries-uterine-fibroid-care
- SACMD.com - sacmd.com/top-ufe-providers-in-dc-why-sacmd-com-stands-out
- Mordor Intelligence - mordorintelligence.com/industry-reports/uterine-fibroids-treatment-market
- American College of Obstetricians and Gynecologists (ACOG) - acog.org/womens-health/faqs/uterine-fibroids
- Society of Interventional Radiology (SIR) - sirweb.org/patients/conditions/uterine-artery-embolization
- U.S. Food and Drug Administration (FDA) - fda.gov/radiation-emitting-products/medical-imaging/mri-guided-focused-ultrasound
- Providence Journal (Press Release) - providencejournal.com/press-release/story/45635
- PMC / Journal of Occupational and Environmental Medicine - pmc.ncbi.nlm.nih.gov/articles/PMC12321346
- Mayo Clinic - mayoclinic.org/diseases-conditions/uterine-fibroids/care-at-mayo-clinic/mac-20354215
- Cleveland Clinic - my.clevelandclinic.org/departments/obgyn/depts/fibroids
- Johns Hopkins Medicine - hopkinsmedicine.org/gynecology-obstetrics/specialty-areas/fibroids
- Penn Medicine - pennmedicine.org/specialties/gynecology/fibroid-care
- Georgia Endovascular - georgiaeva.com/fibroids
- PR Newswire / Atlanta Fibroid Center - prnewswire.com/news-releases/atlanta-fibroid-center-celebrates-20-years-302581122.html
- Texas Endovascular - texaseva.com/fibroids
- California Vascular Associates - cavascular.com/uterine-fibroid-treatment
- Maryland Fibroid Clinic - marylandfibroids.com
- USA Fibroid Centers - usafibroidcenters.com/locations/indiana/indianapolis
- Viva Eve - vivaeve.com/lp/fibroid-specialist-in-nyc
- Fibroid Institute Charleston - fibroidfree.com/clinic/fibroid-institute-charleston
- Premier Endovascular - premier-endovascular.com/our-services/ufe
- SACMD.com (Surgical Associates LLC) - sacmd.com/top-ufe-providers-in-dc-why-sacmd-com-stands-out
- UCSD Clinical Trials / UCSF ULTRA Registry - clinicaltrials.ucsd.edu/uterine-fibroids
- Prospero Vascular and Interventional - prosperovascular.com/fibroid-specialist-san-francisco-minimally-invasive-care-near-me
- Metro Fibroid Center at Image Guided Surgery - metrofibroidcenter.com/stafford-va
- Rutgers Health / Rutgers New Jersey Medical School - rutgershealth.org/news/breaking-boundaries-uterine-fibroid-care
Authored by 24Trendz team